Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yuenong Qin"'
Autor:
Youyang Shi MD, PhD, Yuanyuan Wu MD, Man Shen MD, PhD, Jianfeng Yang MD, PhD, Yuenong Qin MD, Sheng Liu MD, PhD, Chenping Sun MD, PhD
Publikováno v:
Integrative Cancer Therapies, Vol 22 (2023)
Doxorubicin (Dox) is a first-line chemotherapeutic agent applied in cancer treatment. Its long-term anticancer efficacy is restricted mainly due to its subsequent cardiotoxicity for patients. Platycodon grandiflorum (PG), an important traditional Chi
Externí odkaz:
https://doaj.org/article/4e426797d33544d7b1ef11b6652bca67
Autor:
Feifei Li, Youyang Shi, Yang Zhang, Xiaojuan Yang, Yi Wang, Kexin Jiang, Ciyi Hua, Chunyu Wu, Chenping Sun, Yuenong Qin, Sheng Liu
Publikováno v:
Chinese Medicine, Vol 17, Iss 1, Pp 1-20 (2022)
Abstract Background Xian-ling-lian-xia-fang (XLLXF), a Chinese medicine decoction, is widely used in the treatment of triple negative breast cancer (TNBC). However, the underlying mechanism of XLLXF in TNBC treatment has not been totally elucidated.
Externí odkaz:
https://doaj.org/article/5c532938ed9a49e2bec7782f48ecc8b2
Autor:
Chunyu Wu, Chenping Sun, Guangyu Liu, Yuenong Qin, Xiaohong Xue, Xueqing Wu, Qun Wang, Jin Liu, Zhen Ye, Qiong Li, Wenchao Qu, Yi Wang, Shuai Zhang, Zhiming Shao, Sheng Liu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
PurposeTo evaluate the efficacy of the Sanyin formula (SYF) plus conventional standard chemotherapy in operable triple-negative breast cancer (TNBC) patients, a randomized controlled trial was implemented at 5 hospitals and cancer centers in China be
Externí odkaz:
https://doaj.org/article/bf3e12b9953743db9206411e10483f80
Publikováno v:
Pharmaceuticals, Vol 16, Iss 1, p 9 (2022)
Sanyin formula (SYF) is used as a complementary treatment for triple-negative breast cancer (TNBC). The purpose of this study was to identify the potential functional components and clarify the underlying molecular mechanisms of SYF in TNBC. High-per
Externí odkaz:
https://doaj.org/article/36dbe979555d4854a23738f8260b5692
Autor:
Youyang Shi, Feifei Li, Man Shen, Chenpin Sun, Wei Hao, Chunyu Wu, Ying Xie, Shuai Zhang, Hongzhi Gao, Jianfeng Yang, Zhongyan Zhou, Dongwen Gao, Yuenong Qin, Xianghui Han, Sheng Liu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Background: Doxorubicin (Dox) is one of the most effective chemotherapy agents used in the treatment of solid tumors and hematological malignancies. However, it causes dose-related cardiotoxicity that may lead to heart failure in patients. Luteolin (
Externí odkaz:
https://doaj.org/article/8737b41ba0904b3695f895d1aa405b76
Autor:
Wei Hao MD, Youyang Shi MD, Yuenong Qin MD, Chenping Sun MD, Liying Chen MD, Chunyu Wu MD, Yijia Bao MD, Sheng Liu MD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Background: Anthracycline-based chemotherapy is an effective treatment used for early-stage breast cancer patients. However, anthracycline use is limited due to its cardiotoxic effects. Recent studies have shown that Platycodon grandiflorum (PG) prot
Externí odkaz:
https://doaj.org/article/039253249eb64ca89c31c9c0b05c1c45
Publikováno v:
Integrative Cancer Therapies. 22:153473542311646
Doxorubicin (Dox) is a first-line chemotherapeutic agent applied in cancer treatment. Its long-term anticancer efficacy is restricted mainly due to its subsequent cardiotoxicity for patients. Platycodon grandiflorum (PG), an important traditional Chi
Autor:
Wei Hao, Dongwen Gao, Yuenong Qin, Hongzhi Gao, Ying Xie, Xianghui Han, Youyang Shi, Feifei Li, Shuai Zhang, Jianfeng Yang, Chenpin Sun, Chunyu Wu, Man Shen, Zhongyan Zhou, Sheng Liu
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Frontiers in Cardiovascular Medicine
Frontiers in Cardiovascular Medicine
Background: Doxorubicin (Dox) is one of the most effective chemotherapy agents used in the treatment of solid tumors and hematological malignancies. However, it causes dose-related cardiotoxicity that may lead to heart failure in patients. Luteolin (
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Objective. The purpose of this study was to explore the relationship between acute mastitis and the constitution of traditional Chinese medicine (TCM) and the potential risk factors of acute mastitis in Chinese breastfeeding mothers. Method. A retros
Autor:
Youyang Shi, Yijia Bao, Sheng Liu, Wei Hao, Yuenong Qin, Liying Chen, Chenping Sun, Chunyu Wu
Publikováno v:
Integrative Cancer Therapies
Background: Anthracycline-based chemotherapy is an effective treatment used for early-stage breast cancer patients. However, anthracycline use is limited due to its cardiotoxic effects. Recent studies have shown that Platycodon grandiflorum (PG) prot